[go: up one dir, main page]

ES2184633A1 - Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. - Google Patents

Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.

Info

Publication number
ES2184633A1
ES2184633A1 ES200101853A ES200101853A ES2184633A1 ES 2184633 A1 ES2184633 A1 ES 2184633A1 ES 200101853 A ES200101853 A ES 200101853A ES 200101853 A ES200101853 A ES 200101853A ES 2184633 A1 ES2184633 A1 ES 2184633A1
Authority
ES
Spain
Prior art keywords
imidazol
formula
preparation
benzenesulfonamide derivatives
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101853A
Other languages
English (en)
Other versions
ES2184633B1 (es
Inventor
Rosales Carmen Almansa
Gonzalez Concepcion Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200101853A priority Critical patent/ES2184633B1/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to DE60226879T priority patent/DE60226879D1/de
Priority to EP02794802A priority patent/EP1424329B1/en
Priority to ES02794802T priority patent/ES2307817T3/es
Priority to BRPI0211749A priority patent/BRPI0211749B8/pt
Priority to CA2456531A priority patent/CA2456531C/en
Priority to PCT/ES2002/000385 priority patent/WO2003016285A1/es
Priority to JP2003521211A priority patent/JP4309262B2/ja
Priority to DK02794802T priority patent/DK1424329T3/da
Priority to AT02794802T priority patent/ATE396976T1/de
Priority to KR1020047001749A priority patent/KR100888905B1/ko
Priority to MXPA04001147A priority patent/MXPA04001147A/es
Priority to PT02794802T priority patent/PT1424329E/pt
Priority to US10/485,950 priority patent/US7351836B2/en
Priority to ARP020102972A priority patent/AR037231A1/es
Publication of ES2184633A1 publication Critical patent/ES2184633A1/es
Priority to NO20040981A priority patent/NO326162B1/no
Application granted granted Critical
Publication of ES2184633B1 publication Critical patent/ES2184633B1/es
Priority to HK04109044A priority patent/HK1066214A1/xx
Priority to US12/060,574 priority patent/US8476456B2/en
Priority to CY20081100892T priority patent/CY1108861T1/el
Priority to ARP120101436A priority patent/AR086065A2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento para la preparación de derivados de 4-(imidazol-1- il) bencenosulfonamida de fórmula I, donde R1 representa arilo o heteroarilo opcionalmente sustituido, caracterizado porque comprende tratar un compuesto de fórmula II, donde R1 tiene el mismo significado descrito para la fórmula I y But representa tert-butilo, con un ácido adecuado. Los derivados de 4(imidazol- 1-il) bencenosulfonamida de fórmula I son útiles como agentes antiinflamatorios.
ES200101853A 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. Expired - Fee Related ES2184633B1 (es)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
MXPA04001147A MXPA04001147A (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida.
ES02794802T ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.
BRPI0211749A BRPI0211749B8 (pt) 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida
CA2456531A CA2456531C (en) 2001-08-07 2002-08-01 Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida
EP02794802A EP1424329B1 (en) 2001-08-07 2002-08-01 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
DK02794802T DK1424329T3 (da) 2001-08-07 2002-08-01 Fremgangsmåde til fremstillingen af 4-(imidazol-1-yl)benzensulfonamid
AT02794802T ATE396976T1 (de) 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1- yl)benzolsulfonamidderivaten
KR1020047001749A KR100888905B1 (ko) 2001-08-07 2002-08-01 4-(이미다졸-1-일)벤젠술폰아미드 유도체의 제조 방법
DE60226879T DE60226879D1 (de) 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten
JP2003521211A JP4309262B2 (ja) 2001-08-07 2002-08-01 ４−（イミダゾール−１−イル）ベンゼンスルホンアミド誘導体の製造方法
PT02794802T PT1424329E (pt) 2001-08-07 2002-08-01 Processo de preparação de derivados de 4-(imidazol-1-il) benzenossulfonamida
US10/485,950 US7351836B2 (en) 2001-08-07 2002-08-01 Method of preparing 4-(imidazol-1-yl)benzenesulphonamide derivatives
ARP020102972A AR037231A1 (es) 2001-08-07 2002-08-06 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida e compuestos intermedios para la obtencion de los mismos
NO20040981A NO326162B1 (no) 2001-08-07 2004-03-05 Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.
HK04109044A HK1066214A1 (en) 2001-08-07 2004-11-17 Process for the preparation of 4-(imidazol-1-yl) benzenesulfonamide derivatives
US12/060,574 US8476456B2 (en) 2001-08-07 2008-04-01 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
CY20081100892T CY1108861T1 (el) 2001-08-07 2008-08-21 Μεθοδος δια την παρασκευη παραγωγων 4-(ιμιδαζολ-1-υλ)-βενζολοσουλφοναμιδης
ARP120101436A AR086065A2 (es) 2001-08-07 2012-04-25 Compuestos de imidazolsulfonamidas y un proceso para su produccion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.

Publications (2)

Publication Number Publication Date
ES2184633A1 true ES2184633A1 (es) 2003-04-01
ES2184633B1 ES2184633B1 (es) 2004-08-01

Family

ID=8498662

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200101853A Expired - Fee Related ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
ES02794802T Expired - Lifetime ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02794802T Expired - Lifetime ES2307817T3 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfanomida.

Country Status (17)

Country Link
US (2) US7351836B2 (es)
EP (1) EP1424329B1 (es)
JP (1) JP4309262B2 (es)
KR (1) KR100888905B1 (es)
AR (2) AR037231A1 (es)
AT (1) ATE396976T1 (es)
BR (1) BRPI0211749B8 (es)
CA (1) CA2456531C (es)
CY (1) CY1108861T1 (es)
DE (1) DE60226879D1 (es)
DK (1) DK1424329T3 (es)
ES (2) ES2184633B1 (es)
HK (1) HK1066214A1 (es)
MX (1) MXPA04001147A (es)
NO (1) NO326162B1 (es)
PT (1) PT1424329E (es)
WO (1) WO2003016285A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015000507A2 (pt) 2012-07-12 2017-06-27 Chiesi Farm Spa inibição de enzimas
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate
KR102703324B1 (ko) * 2022-11-08 2024-09-06 국민대학교산학협력단 아미노벤즈이미다졸 유도체 및 이의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064415A1 (en) * 1998-06-11 1999-12-16 Pfizer Pharmaceuticals Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
WO2000023426A1 (es) * 1998-10-16 2000-04-27 J. Uriach & Cia, S.A. Nuevos imidazoles con actividad antiinflamatoria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4216475B2 (ja) * 1998-07-02 2009-01-28 クリプターグラフィー リサーチ インコーポレイテッド 漏洩抵抗力を有する暗号索引付き鍵の更新方法及びデバイス
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064415A1 (en) * 1998-06-11 1999-12-16 Pfizer Pharmaceuticals Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
WO2000023426A1 (es) * 1998-10-16 2000-04-27 J. Uriach & Cia, S.A. Nuevos imidazoles con actividad antiinflamatoria

Also Published As

Publication number Publication date
BRPI0211749B8 (pt) 2021-05-25
US20090012307A1 (en) 2009-01-08
NO20040981L (no) 2004-03-05
AR037231A1 (es) 2004-11-03
JP4309262B2 (ja) 2009-08-05
MXPA04001147A (es) 2004-07-08
BR0211749B1 (pt) 2013-09-10
KR100888905B1 (ko) 2009-03-16
US20040242872A1 (en) 2004-12-02
CY1108861T1 (el) 2014-08-13
DE60226879D1 (de) 2008-07-10
EP1424329B1 (en) 2008-05-28
ES2184633B1 (es) 2004-08-01
ES2307817T3 (es) 2008-12-01
NO326162B1 (no) 2008-10-13
US7351836B2 (en) 2008-04-01
CA2456531A1 (en) 2003-02-27
WO2003016285A1 (es) 2003-02-27
PT1424329E (pt) 2008-08-06
DK1424329T3 (da) 2008-09-29
CA2456531C (en) 2010-12-14
KR20040020079A (ko) 2004-03-06
BR0211749A (pt) 2004-10-13
EP1424329A1 (en) 2004-06-02
WO2003016285A8 (es) 2003-08-28
US8476456B2 (en) 2013-07-02
ATE396976T1 (de) 2008-06-15
JP2005502659A (ja) 2005-01-27
AR086065A2 (es) 2013-11-13
HK1066214A1 (en) 2005-03-18

Similar Documents

Publication Publication Date Title
GB9801690D0 (en) Therapeutic agents
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
MXPA03010961A (es) Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
AU2002239344A1 (en) Pyrazolopyridines
WO2002096905A8 (en) Thiazole compounds useful as inhibitors of protein kinases
MXPA04001685A (es) Derivados de sulfonilamino empleados como herbicida.
WO2002085906A3 (en) Phthalazinones derivatives useful as pde4/7 inhibitors
TR28332A (tr) Arilasetik asit türevleri.
DE60116589D1 (de) Fungizide Phenylamidinderivative
WO2003053971A8 (en) Pyridoquinoxaline antivirals
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
TR200200745T2 (tr) Fenilasetik asit türevleri için proses.
ES2184633A1 (es) Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
ATE297902T1 (de) Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
DE60108209D1 (de) Fungizide Phenylimidate-Derivate
GB0103046D0 (en) Organic Compounds
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
ATE319708T1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030401

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2184633B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211118